KCT0001425已完成未知
Bioequivalence study of 'Eifen tablet' produced by Daewoo Pharmaceutical Co.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 55(Year)（—）
- 性别
- All
入选标准
- •19~55 years old volunteers when they were exmined.
- •volunteers without both any inherited or chronic diseases and any pathologic symptoms/signs in physical examination
- •healthy volunteers judged by resulting from hematology, blood chemistry and urinalysis
- •no pregnant woman
排除标准
- •A person who administered any drug enzyme inducers/inhibitors and heavy alcohol within a month before starting this study
- •A person who administered any medicine which may affect this study within 10 days before initiation
- •A person judged as an inappropriate volunteer by the physician in charge
研究者
相似试验
未知
1 期
DMB-3111 phase IHealthy volunteersJPRN-jRCT2080222436Meiji Seika Pharma Co., Ltd.70
招募中
不适用
In-vivo Bioequivalence Test of Ibuprofen tablet 800 mg Mofid Pharma with brand drug (BRUFEN® ER. 800 mg Tab, Mylan, Germany)Bio equivalence test.IRCT20200105046010N67Teb Mofid Nikan Pharmaceutical Co.24
已完成
1 期
Bioequivalence (BE) study of a new branded generic of Etoricoxib (ETO) tabletEtoricoxib could commonly cause edema, dizziness, headache, palpitations, arrhythmia, hypertension, bronchospasm, constipation, heartburn and gastritis.Bioequivalence studyEtoricoxibgenericsTCTR20210714009/A24
进行中（未招募）
不适用
A Study to Assess the Pharmacologic Equivalence of Two Orlistat Dosage FormsEUCTR2008-006986-10-GBGlaxoSmithKline Consumer Healthcare
进行中（未招募）
不适用
A Study to Assess the Pharmacologic Equivalence of Two Orlistat Dosage FormsEUCTR2007-004797-79-GBGlaxoSmithKline Consumer Healthcare